NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
Take a deep dive with the best Investors in MicroCapEDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
明尼蘇達州伊甸草坪 / ACCESSWIRE / 2024年11月13日 / 神經元醫療科技公司（納斯達克：NMTC）（"NeuroOne"或"公司"），是一家專注於改善神經系統疾病患者外科護理選擇和結果的醫療科技公司，今天宣佈將參加虛擬投資者峯會微型資本活動。除演示外，該公司還將在整個過程中提供一對一會議。
Event: Q4 Investor Summit
Date: Thursday, November 21, 2024
Presentation Time: 1:30pm - 2:00pm ET
Location:
活動：Q4投資者峯會
日期：2024年11月21日，星期四
演示時間：下午1:30 - 2:00 ET
位置：
The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.
Take a deep dive with the best Investors in MicroCap
Live Q & A
Complimentary to Qualified Investors. Please REGISTER HERE.
該主題是具有催化劑和/或在當前市場表現強勁的40家微小市值公司。
與MicroCap最佳投資者深入探討。
實時問答。
僅供合格投資者免費註冊。請在此處註冊。
About the Investor Summit
關於投資者峯會
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.
投資者峯會是一家專注於連接小市值和微市值公司與合格投資者的獨立會議。創立於2015年。
About NeuroOne
NeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit .
關於NeuroOne
NeuroOne 醫療 科技公司正在開發和商業化微創和高清晰度的解決方案，用於腦電圖記錄、腦刺激和消融，幫助患有癲癇、帕金森病、肌張力障礙、基本顫動、由於背部手術失敗導致的慢性疼痛以及其他相關神經系統疾病的患者，以改善患者的治療效果和降低程序成本。該公司還可能在其他領域追求應用，如抑鬱症、情緒障礙、疼痛、失禁、高血壓和人工智能。如需更多信息，請訪問。
Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group
聯繫方式：
弗雷德·洛克威爾
fred@investorsummitgroup.com
投資者峯會集團
NMTC IR Contact
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group - MZ North America
NMTC@mzgroup.us
(949) 694-9594
NMTC IR 聯繫方式
Quinn Callanan，CFA 或 Brian Prenoveau，CFA
MZ Group - MZ North America
NMTC@mzgroup.us
(949) 694-9594
SOURCE: NeuroOne Medical Technologies Corporation
來源：神經元醫療科技公司
譯文內容由第三人軟體翻譯。
